{"schema_version":"secwatch.filing_event.v1","accession":"0000055529-26-000006","form_type":"8-K","ticker":"KEQU","cik":"0000055529","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","filed_at":"2026-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.446839+00:00","generated_at":"2026-05-15T15:16:43.386987+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Kewaunee Scientific Q3 sales +3.3% to $69.4M; diluted EPS $0.23 vs $0.45; backlog down 17% YoY","bullets":["Sales $69.4M (+3.3% YoY); pre-tax earnings $1.6M (+25.8%).","Net earnings attributable to Kewaunee $692K (diluted EPS $0.23) vs $1.35M ($0.45) prior year.","Domestic segment sales -2.0% to $50.95M; International segment sales +21.4% to $18.45M.","Order backlog $183.2M on Jan 31, 2026, down from $221.6M a year ago.","Long-term debt net of sale-leaseback reduced to $16.3M from $34.1M at fiscal year end."],"urls":{"canonical":"https://secwatch.observer/filing/0000055529-26-000006","json":"https://secwatch.observer/filing/0000055529-26-000006.json","markdown":"https://secwatch.observer/filing/0000055529-26-000006.md","text":"https://secwatch.observer/filing/0000055529-26-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55529/000005552926000006/0000055529-26-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55529/000005552926000006/kequ-20260311.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T15:16:43.386987+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7f57b60dd25b341bb7481660a4835042723079a3","claim":"KEWAUNEE SCIENTIFIC CORP /DE/ reported third quarter ended January 31, 2026 results: revenue $69,399,000, net income $692,000, EPS $0.23.","evidence_excerpt":"Sales during the third quarter of fiscal year 2026 were $69,399,000, an increase of 3.3% compared to sales of $67,167,000 from the prior year's third quarter. Pre-tax earnings for the quarter were $1,604,000 compared to $1,275,000 for the prior year quarter, an increase of 25.8%. Net earnings were $692,000 compared to net earnings of $1,354,000 for the prior year quarter. EBITDA 1 for the quarter was $3,795,000 compared to $3,734,000 for the prior year quarter. Diluted earnings per share were $0.23 compared to diluted earnings per share of $0.45 in the prior year quarter.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/55529/000005552926000006/0000055529-26-000006-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended January 31, 2026"},{"label":"Revenue","value":"$69,399,000"},{"label":"Net income","value":"$692,000"},{"label":"EPS","value":"$0.23"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}